- Home
- MTEX vs CASI Comparison
MTEX vs CASI Comparison
Compare MTEX & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- CASI
- Stock Information
- Founded
- MTEX 1993
- CASI 1991
- Country
- MTEX United States
- CASI China
- Employees
- MTEX N/A
- CASI N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- CASI Health Care
- Exchange
- MTEX Nasdaq
- CASI Nasdaq
- Market Cap
- MTEX 20.0M
- CASI 20.5M
- IPO Year
- MTEX 1999
- CASI 1996
- Fundamental
- Price
- MTEX $7.86
- CASI $1.27
- Analyst Decision
- MTEX
- CASI Strong Buy
- Analyst Count
- MTEX 0
- CASI 1
- Target Price
- MTEX N/A
- CASI $4.00
- AVG Volume (30 Days)
- MTEX 21.1K
- CASI 42.8K
- Earning Date
- MTEX 08-12-2025
- CASI 08-15-2025
- Dividend Yield
- MTEX N/A
- CASI N/A
- EPS Growth
- MTEX N/A
- CASI N/A
- EPS
- MTEX N/A
- CASI N/A
- Revenue
- MTEX $115,036,000.00
- CASI $31,368,000.00
- Revenue This Year
- MTEX N/A
- CASI N/A
- Revenue Next Year
- MTEX N/A
- CASI N/A
- P/E Ratio
- MTEX N/A
- CASI N/A
- Revenue Growth
- MTEX N/A
- CASI 8.39
- 52 Week Low
- MTEX $7.00
- CASI $1.09
- 52 Week High
- MTEX $16.49
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- MTEX 35.35
- CASI 39.21
- Support Level
- MTEX $8.10
- CASI $1.21
- Resistance Level
- MTEX $8.50
- CASI $1.44
- Average True Range (ATR)
- MTEX 0.56
- CASI 0.12
- MACD
- MTEX -0.10
- CASI 0.02
- Stochastic Oscillator
- MTEX 0.00
- CASI 48.78
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.